Mechanisms of microglial activation by amyloid precursor protein and its proteolytic fragments

Central Nervous System Diseases and Inflammation

Volumn , Issue , 2008, Pages 13-32

  Austin, S A ^a   Combs, C K ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84900126183     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-73894-9_2     Document Type: Chapter

References (162)

1. Akiyama, H., Arai, T., Kondo, H., Tanno, E., Haga, C. and Ikeda, K. (2000). Cell mediators of inflammation in the Alzheimer disease brain. Alzheimer Dis Assoc Disord, 14 Suppl 1, S47-S53
2. Bamberger, ME., Harris, M. E., McDonald, D. R., Husemann, J. and Landreth, G. E. (2003). A cell surface receptor complex for fibrillar beta-Amyloid mediates microglial activation. J Neurosci, 23, 2665-2674
3. Banati, R. B., Gehrmann, J., Czech, C., Monning, U., Jones, L. L., Konig, G., Beyreuther, K. and Kreutzberg, G. W. (1993). Early and rapid de novo synthesis of Alzheimer beta A4-Amyloid precursor protein (APP) in activated microglia. Glia, 9, 199-210
4. Banati, R. B., Gehrmann, J. and Kreutzberg, G. W. (1994). Glial beta-Amyloid precursor protein: Expression in the dentate gyrus after entorhinal cortex lesion. Neuroreport, 5, 1359-1361
5. Banati, R. B., Gehrmann, J., Lannes-Vieira, J., Wekerle, H. and Kreutzberg, G. W. (1995a). Inflammatory reaction in experimental autoimmune encephalomyelitis (EAE) is accompanied by a microglial expression of the beta A4-Amyloid precursor protein (APP). Glia, 14, 209-215
6. Banati, R. B., Gehrmann, J., Wiessner, C., Hossmann, K. A. and Kreutzberg, G. W. (1995b). Glial expression of the beta-Amyloid precursor protein (APP) in global ischemia. J Cereb Blood Flow Metab, 15, 647-654
7. Barger, S. W. and Basile, A. S. (2001). Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function. J Neurochem, 76, 846-854
8. Barger, S. W. and Harmon, A. D. (1997). Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature, 388, 878-881
9. Barger, S. W. and Mattson, M. P. (1995). The secreted form of the Alzheimer's beta-Amyloid precursor protein stimulates a membrane-Associated guanylate cyclase. Biochem J, 311 (Pt 1), 45-47
10. Barger, S. W. and Mattson, M. P. (1996). Induction of neuroprotective kappa B-dependent transcription by secreted forms of the Alzheimer's beta-Amyloid precursor. Brain Res Mol Brain Res, 40, 116-126
11. Barger, S. W. and Mattson, M. P. (1997). Isoform-specific modulation by apolipoprotein E of the activities of secreted beta-Amyloid precursor protein. J Neurochem, 69, 60-67
12. Barger, S. W., Chavis, J. A. and Drew, P. D. (2000). Dehydroepiandrosterone inhibits microglial nitric oxide production in a stimulus-specific manner. J Neurosci Res, 62, 503-509
13. Bauer, J., Konig, G., Strauss, S., Jonas, U., Ganter, U., Weidemann, A., Monning, U., Masters, C. L., Volk, B., Berger, M., et al. (1991). In-vitro matured human macrophages express Alzheimer's beta A4-Amyloid precursor protein indicating synthesis in microglial cells. FEBS Lett, 282, 335-340
14. Beher, D., Hesse, L., Masters, C. L. and Multhaup, G. (1996). Regulation of amyloid protein precursor (APP) binding to collagen and mapping of the binding sites on APP and collagen type I. J Biol Chem, 271, 1613-1620
15. Bennett, B. D., Babu-Khan, S., Loeloff, R., Louis, J. C., Curran, E., Citron, M. and Vassar, R. (2000). Expression analysis of BACE2 in brain and peripheral tissues. J Biol Chem, 275, 20647-20651
16. Bi, X., Gall, C. M., Zhou, J. and Lynch, G. (2002). Uptake and pathogenic effects of amyloid beta peptide 1-42 are enhanced by integrin antagonists and blocked by NMDA receptor antagonists. Neuroscience, 112, 827-840
17. Bianca, V. D., Dusi, S., Bianchini, E., Dal Pra, I. and Rossi, F. (1999). Beta-Amyloid activates the O-2 forming NADPH oxidase in microglia, monocytes, and neutrophils. A possible inflammatory mechanism of neuronal damage in Alzheimer's disease. J Biol Chem, 274, 15493-15499
18. Bodles, A. M. and Barger, S. W. (2005). Secreted beta-Amyloid precursor protein activates microglia via JNK and p38-MAPK. Neurobiol Aging, 26, 9-16
19. Boland, K., Manias, K and Perlmutter, D. H. (1995). Specificity in recognition of amyloid-beta peptide by the serpin-enzyme complex receptor in hepatoma cells and neuronal cells. J Biol Chem, 270, 28022-28028
20. Borg, J. P., Ooi, J., Levy, E. and Margolis, B. (1996). The phosphotyrosine interaction Domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein. Mol Cell Biol, 16, 6229-6241
21. Braak, H. and Braak, E. (1997a). Diagnostic criteria for neuropathologic assessment of Alzheimer's disease. Neurobiol Aging, 18, S85-S88
22. Braak, H. and Braak, E. (1997b). Frequency of stages of Alzheimer-related lesions in Different age categories. Neurobiol Aging, 18, 351-357
23. Bressler, S. L., Gray, M. D., Sopher, B. L., Hu, Q., Hearn, M. G., Pham, D. G., Dinulos, M. B., Fukuchi, K., Sisodia, S. S., Miller, M. A., Disteche, C. M. and Martin, G. M. (1996). cDNA cloning and chromosome mapping of the human Fe65 gene: Interaction of the conserved cytoplasmic domains of the human beta-Amyloid precursor protein and its homologues with the mouse Fe65 protein. Hum Mol Genet, 5, 1589-1598
24. Cai, X. D., Golde, T. E. and Younkin, S. G. (1993). Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. Science, 259, 514-516
25. Chartier-Harlin, M. C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., Goate, A., Rossor, M., Roques, P., Hardy, J., et al. (1991). Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-Amyloid precursor protein gene. Nature, 353, 844-846
26. Chong, Y. H., Shin, Y. J., Lee, E. O., Kayed, R., Glabe, C. G. and Tenner, A. J. (2006). ERK1/2 activation mediates Abeta oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice cultures. J Biol Chem, 281, 20315-20325
27. Chromy, B. A., Nowak, R. J., Lambert, M. P., Viola, K. L., Chang, L., Velasco, P. T., Jones, B. W., Fernandez, S. J., Lacor, P. N., Horowitz, P., Finch, C. E., Krafft, G. A. and Klein, W. L. (2003). Self-Assembly of Abeta(1-42) into globular neurotoxins. Biochemistry, 42, 12749-12760
28. Chung, H., Brazil, M I., Soe, T. T. and Maxfield, F. R. (1999). Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer's amyloid beta-peptide by microglial cells. J Biol Chem, 274, 32301-32308
29. Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I. and Selkoe, D. J. (1992). Mutation of the beta-Amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature, 360, 672-674
30. Citron, M., Vigo-Pelfrey, C., Teplow, D. B., Miller, C., Schenk, D., Johnston, J., Winblad, B., Venizelos, N., Lannfelt, L. and Selkoe, D. J. (1994). Excessive production of amyloid betaprotein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation. Proc Natl Acad Sci U S A, 91, 11993-11997
31. Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J. and Ashe, K. H. (2005). Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci, 8, 79-84
32. Combs, C K., Johnson, D. E., Cannady, S. B., Lehman, T. M. and Landreth, G. E. (1999). Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of beta-Amyloid and prion proteins. J Neurosci, 19, 928-939
33. Combs, C K., Johnson, D. E., Karlo, J. C., Cannady, S. B. and Landreth, G. E. (2000). Inflammatory mechanisms in Alzheimer's disease: Inhibition of beta-Amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists. J Neurosci, 20, 558-567
34. Combs, C K., Karlo, J. C., Kao, S. C. and Landreth, G. E. (2001). Beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J Neurosci, 21, 1179-1188
35. Coraci, IS., Husemann, J., Berman, J. W., Hulette, C., Dufour, J. H., Campanella, G. K., Luster, A. D., Silverstein, S. C. and El-Khoury, J. B. (2002). CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-Amyloid fibrils. Am J Pathol, 160, 101-112
36. Dahlgren, KN., Manelli, A. M., Stine, W. B., Jr., Baker, L. K., Krafft, G. A. and LaDu, M. J. (2002). Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J Biol Chem, 277, 32046-32053
37. Demuro, A., Mina, E., Kayed, R., Milton, S C., Parker, I. and Glabe, C. G. (2005). Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem, 280, 17294-17300
38. Deshpande, A., Mina, E., Glabe, C. and Busciglio, J. (2006). Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons. J Neurosci, 26, 6011-6018
39. Dickson, D. W., Lee, S. C., Mattiace, L. A., Yen, S. H. and Brosnan, C. (1993). Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia, 7, 75-83
40. Eikelenboom, P., Hack, C. E., Rozemuller, J. M. and Stam, F. C. (1989). Complement activation in amyloid plaques in Alzheimer's dementia. Virchows Arch B Cell Pathol Incl Mol Pathol, 56, 259-262
41. El Khoury, J., Hickman, S. E., Thomas, C. A., Cao, L., Silverstein, S. C. and Loike, J. D. (1996). Scavenger receptor-mediated adhesion of microglia to beta-Amyloid fibrils. Nature, 382, 716-719
42. Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., McClure, D. and Ward, P. J. (1990). Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science, 248, 1122-1124
43. Floden, A M. and Combs, C. K. (2006). Beta-Amyloid stimulates murine postnatal and adult microglia cultures in a unique manner. J Neurosci, 26, 4644-8
44. Floden, A M., Li, S. and Combs, C. K. (2005). Beta-Amyloid-stimulated microglia induce neuron Death via synergistic stimulation of tumor necrosis factor alpha and NMDA receptors. J Neurosci, 25, 2566-75
45. Franciosi, S., Choi, H B., Kim, S. U. and McLarnon, J. G. (2005). IL-8 enhancement of amyloidbeta (Abeta 1-42)-induced expression and production of pro-inflammatory cytokines and COX-2 in cultured human microglia. J Neuroimmunol, 159, 66-74
46. Furukawa, K. and Mattson, M. P. (1998). Secreted amyloid precursor protein alpha selectively suppresses N-methyl-d-Aspartate currents in hippocampal neurons: Involvement of cyclic GMP. Neuroscience, 83, 429-438
47. Furukawa, K., Sopher, B. L., Rydel, R. E., Begley, J. G., Pham, D. G., Martin, G. M., Fox, M. and Mattson, M. P. (1996). Increased activity-regulating and neuroprotective efficacy of alphasecretase-derived secreted amyloid precursor protein conferred by a C-Terminal heparinbinding domain. J Neurochem, 67, 1882-1896
48. Gasic-Milenkovic, J., Dukic-Stefanovic, S., Deuther-Conrad, W., Gartner, U. and Munch, G. (2003). Beta-Amyloid peptide potentiates inflammatory responses induced by lipopolysaccharide, interferon-gamma and 'advanced glycation endproducts' in a murine microglia cell line. Eur J Neurosci, 17, 813-821
49. Giri, R K., Selvaraj, S. K. and Kalra, V. K. (2003). Amyloid peptide-induced cytokine and chemokine expression in THP-1 monocytes is blocked by small inhibitory RNA duplexes for early growth response-1 messenger RNA. J Immunol, 170, 5281-5294
50. Giulian, D., Haverkamp, L. J., Li, J., Karshin, W. L., Yu, J., Tom, D., Li, X. and Kirkpatrick, J. B. (1995). Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain. Neurochem Int, 27, 119-137
51. Gong, Y., Chang, L., Viola, K. L., Lacor, P. N., Lambert, M. P., Finch, C. E., Krafft, G. A. and Klein, W. L. (2003). Alzheimer's disease-Affected brain: Presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc Natl Acad Sci U S A, 100, 10417-10422
52. Gordon, M. N., Holcomb, L. A., Jantzen, P. T., DiCarlo, G., Wilcock, D., Boyett, K. W., Connor, K., Melachrino, J., O'Callaghan, J. P. and Morgan, D. (2002). Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1 + APP mouse. Exp Neurol, 173, 183-195
53. Griffin, W S., Sheng, J. G., Roberts, G. W. and Mrak, R. E. (1995). Interleukin-1 expression in Different plaque types in Alzheimer's disease: Significance in plaque evolution. J Neuropathol Exp Neurol, 54, 276-281
54. Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M. and Binder, L. I. (1986). Abnormal phosphorylation of the microtubule- Associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A, 83, 4913-4917
55. Haass, C., Hung, A. Y. and Selkoe, D. J. (1991). Processing of beta-Amyloid precursor protein in microglia and astrocytes favors an internal localization over constitutive secretion. J Neurosci, 11, 3783-3793
56. Hardy, J. A. and Higgins, G. A. (1992). Alzheimer's disease: The amyloid cascade hypothesis. Science, 256, 184-185
57. Hashimoto, Y., Tsuji, O., Niikura, T., Yamagishi, Y., Ishizaka, M., Kawasumi, M., Chiba, T., Kanekura, K., Yamada, M., Tsukamoto, E., Kouyama, K., Terashita, K., Aiso, S., Lin, A. and Nishimoto, I. (2003). Involvement of c-Jun N-Terminal kinase in amyloid precursor proteinmediated neuronal cell death. J Neurochem, 84, 864-877
58. Hashioka, S., A. Monji, T. Ueda, S. Kanba and H. Nakanishi (2005). Amyloid-beta fibril formation is not necessarily required for microglial activation by the peptides. Neurochem Int, 47, 369-376
59. Hendriks, L., van Duijn, C. M., Cras, P., Cruts, M., Van Hul, W., van Harskamp, F., Warren, A., McInnis, M. G., Antonarakis, S. E., Martin, J. J., et al. (1992). Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-Amyloid precursor protein gene. Nat Genet, 1, 218-221
60. Hsia, A. Y., Masliah, E., McConlogue, L., Yu, G. Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R. C., Nicoll, R. A. and Mucke, L. (1999). Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc Natl Acad Sci U S A, 96, 3228-3233
61. Hu, J., Akama, K. T., Krafft, G. A., Chromy, B. A. and Van Eldik, L. J. (1998). Amyloid-beta peptide activates cultured astrocytes: Morphological alterations, cytokine induction and nitric oxide release. Brain Res, 785, 195-206
62. Hung, A. Y., Koo, E. H., Haass, C. and Selkoe, D. J. (1992). Increased expression of beta-Amyloid precursor protein During neuronal differentiation is not accompanied by secretory cleavage. Proc Natl Acad Sci U S A, 89, 9439-9443
63. Ii, M., Sunamoto, M., Ohnishi, K. and Ichimori, Y. (1996). Beta-Amyloid protein-dependent nitric oxide production from microglial cells and neurotoxicity. Brain Res, 720, 93-100
64. Ikezu, T., Luo, X., Weber, G. A., Zhao, J., McCabe, L., Buescher, J. L., Ghorpade, A., Zheng, J. and Xiong, H. (2003). Amyloid precursor protein-processing products affect mononuclear phagocyte activation: Pathways for sAPP- And Abeta-mediated neurotoxicity. J Neurochem, 85, 925-934
65. Itagaki, S., McGeer, P. L., Akiyama, H., Zhu, S. and Selkoe, D. (1989). Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J Neuroimmunol, 24, 173-182
66. Jarrett, J. T., Berger, E. P. and Lansbury, P. T., Jr. (1993). The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease. Biochemistry, 32, 4693-4697
67. Jin, L. W., Ninomiya, H., Roch, J. M., Schubert, D., Masliah, E., Otero, D. A. and Saitoh, T. (1994). Peptides containing the RERMS sequence of amyloid beta/A4 protein precursor bind cell surface and promote neurite extension. J Neurosci, 14, 5461-5470
68. Kang, J., Lemaire, H. G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K. H., Multhaup, G., Beyreuther, K. and Muller-Hill, B. (1987). The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature, 325, 733-736
69. Kibbey, M. C., Jucker, M., Weeks, B. S., Neve, R. L., Van Nostrand, W. E. and Kleinman, H. K. (1993). Beta-Amyloid precursor protein binds to the neurite-promoting IKVAV site of laminin. Proc Natl Acad Sci U S A, 90, 10150-10153
70. Kingham, P. J. and Pocock, J. M. (2001). Microglial secreted cathepsin B induces neuronal apoptosis. J Neurochem, 76, 1475-1484
71. Klyubin, I., Walsh, D. M., Lemere, C. A., Cullen, W. K., Shankar, G. M., Betts, V., Spooner, E. T., Jiang, L., Anwyl, R., Selkoe, D. J. and Rowan, M. J. (2005). Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo. Nat Med, 11, 556-561
72. Koenigsknecht, J. and Landreth, G. (2004). Microglial phagocytosis of fibrillar beta-Amyloid through a beta1 integrin-dependent mechanism. J Neurosci, 24, 9838-9846
73. Koistinaho, M., Kettunen, M. I., Goldsteins, G., Keinanen, R., Salminen, A., Ort, M., Bures, J., Liu, D., Kauppinen, R. A., Higgins, L. S. and Koistinaho, J. (2002). Beta-Amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: Role of inflammation. Proc Natl Acad Sci U S A, 99, 1610-1515
74. Kokubo, H., Kayed, R., Glabe, C. G. and Yamaguchi, H. (2005). Soluble Abeta oligomers ultrastructurally localize to cell processes and might be related to synaptic dysfunction in Alzheimer's disease brain. Brain Res, 1031, 222-228
75. Lacor, P. N., Buniel, M. C., Chang, L., Fernandez, S. J., Gong, Y., Viola, K. L., Lambert, M. P., Velasco, P. T., Bigio, E. H., Finch, C. E., Krafft, G. A. and Klein, W. L. (2004). Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J Neurosci, 24, 10191-10200
76. Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., Wals, P., Zhang, C., Finch, C. E., Krafft, G. A. and Klein, W. L. (1998). Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A, 95, 6448-6453
77. LeBlanc, A. C., Chen, H. Y., Autilio-Gambetti, L. and Gambetti, P. (1991). Differential APP gene expression in rat cerebral cortex, meninges, and primary astroglial, microglial and neuronal cultures. FEBS Lett, 292, 171-178
78. Lesne, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M. and Ashe, K. H. (2006). A specific amyloid-beta protein assembly in the brain impairs memory. Nature, 440, 352-357
79. Li, Y., Liu, L., Kang, J., Sheng, J. G., Barger, S. W., Mrak, R. E. and Griffin, W. S. (2000). Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression. J Neurosci, 20, 149-155
80. Li, M., Pisalyaput, K., Galvan, M. and Tenner, A. J. (2004). Macrophage colony stimulatory factor and interferon-gamma trigger distinct mechanisms for augmentation of beta-Amyloidinduced microglia-mediated neurotoxicity. J Neurochem, 91, 623-633
81. Lindberg, C., Selenica, M. L., Westlind-Danielsson, A. and Schultzberg, M. (2005). Beta-Amyloid protein structure determines the nature of cytokine release from rat microglia. J Mol Neurosci, 27, 1-12
82. Lorenzo, A. and Yankner, B. A. (1996). Amyloid fibril toxicity in Alzheimer's disease and diabetes. Ann N Y Acad Sci, 777, 89-95
83. Lorenzo, A., Yuan, M., Zhang, Z., Paganetti, P. A., Sturchler-Pierrat, C., Staufenbiel, M., Mautino, J., Vigo, F. S., Sommer, B. and Yankner, B. A. (2000). Amyloid beta interacts with the amyloid precursor protein: A potential toxic mechanism in Alzheimer's disease. Nat Neurosci, 3, 460-464
84. Lu, D. C., Shaked, G. M., Masliah, E., Bredesen, D. E. and Koo, E. H. (2003). Amyloid beta protein toxicity mediated by the formation of amyloid-beta protein precursor complexes. Ann Neurol, 54, 781-789
85. Lue, L. F., Walker, D. G. and Rogers, J. (2001). Modeling microglial activation in Alzheimer's disease with human postmortem microglial cultures. Neurobiol Aging, 22, 945-956
86. Lue, L. F., Kuo, Y. M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E. and Rogers, J. (1999). Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol, 155, 853-862
87. Luterman, J. D., Haroutunian, V., Yemul, S., Ho, L., Purohit, D., Aisen, P. S., Mohs, R. and Pasinetti, G. M. (2000). Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia. Arch Neurol, 57, 1153-1160
88. Manelli, A. M., Bulfinch, L. C., Sullivan, P. M. and Ladu, M. J. (2006). Abeta42 neurotoxicity in primary co-cultures: Effect of apoE isoform and Abeta conformation. Neurobiol Aging, 1558-1497
89. Martin, L. J., Pardo, C. A., Cork, L. C. and Price, D. L. (1994). Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex. Am J Pathol, 145, 1358-1381
90. Masters, C. L., Multhaup, G., Simms, G., Pottgiesser, J., Martins, R. N. and Beyreuther, K. (1985). Neuronal origin of a cerebral amyloid: Neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. EMBO J, 4, 2757-2763
91. Matsuda, S., Yasukawa, T., Homma, Y., Ito, Y., Niikura, T., Hiraki, T., Hirai, S., Ohno, S., Kita, Y., Kawasumi, M., Kouyama, K., Yamamoto, T., Kyriakis, J. M. and Nishimoto, I. (2001). c-Jun N-Terminal kinase (JNK)-interacting protein-1b/islet-brain-1 scaffolds Alzheimer's amyloid precursor protein with JNK. J Neurosci, 21, 6597-6607
92. Mattiace, L. A., Davies, P., Yen, S. H. and Dickson, D. W. (1990). Microglia in cerebellar plaques in Alzheimer's disease. Acta Neuropathol (Berl), 80, 493-498
93. McDonald, D R., Brunden, K. R. and Landreth, G. E. (1997). Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia. J Neurosci, 17, 2284-2294
94. McDonald, D R., Bamberger, M. E., Combs, C. K. and Landreth, G. E. (1998). Beta-Amyloid fibrils activate parallel mitogen-Activated protein kinase pathways in microglia and THP1 monocytes. J Neurosci, 18, 4451-4460
95. McGeer, P. L., Kamo, H., Harrop, R., McGeer, E. G., Martin, W. R., Pate, B. D. and Li, D. K. (1986). Comparison of PET, MRI, and CT with pathology in a proven case of Alzheimer's disease. Neurology, 36, 1569-1574
96. McLean, C. A., Cherny, R. A., Fraser, F. W., Fuller, S. J., Smith, M. J., Beyreuther, K., Bush, A. I. and Masters, C. L. (1999). Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol, 46, 860-866
97. Miyazono, M., Iwaki, T., Kitamoto, T., Kaneko, Y., Doh-ura, K. and Tateishi, J. (1991). A comparative immunohistochemical study of Kuru and senile plaques with a special reference to glial reactions at various stages of amyloid plaque formation. Am J Pathol, 139, 589-598
98. Monning, U., Sandbrink, R., Weidemann, A., Banati, R. B., Masters, C. L. and Beyreuther, K. (1995). Extracellular matrix influences the biogenesis of amyloid precursor protein in microglial cells. J Biol Chem, 270, 7104-7110
99. Monsonego, A., Imitola, J., Zota, V., Oida, T. and Weiner, H. L. (2003). Microglia-mediated nitric oxide cytotoxicity of T cells following amyloid beta-peptide presentation to Th1 cells. J Immunol, 171, 2216-2224
100. Mook-Jung, I. and Saitoh, T. (1997). Amyloid precursor protein activates phosphotyrosine signaling pathway. Neurosci Lett, 235, 1-4
101. Moore, K J., El Khoury, J., Medeiros, L. A., Terada, K., Geula, C., Luster, A. D. and Freeman, M. W. (2002). A CD36-initiated signaling cascade mediates inflammatory effects of beta-Amyloid. J Biol Chem, 277, 47373-47379
102. Morgan, D., Gordon, M. N., Tan, J., Wilcock, D. and Rojiani, A. M. (2005). Dynamic complexity of the microglial activation response in transgenic models of amyloid deposition: Implications for Alzheimer therapeutics. J Neuropathol Exp Neurol, 64, 743-753.
103. Morris, J. C., Storandt, M., McKeel, D. W., Jr., Rubin, E. H., Price, J. L., Grant, E. A. and Berg, L. (1996). Cerebral amyloid deposition and diffuse plaques in 'normal' aging: Evidence for presymptomatic and very mild Alzheimer's disease. Neurology, 46, 707-719
104. Mrak, R. E. and Griffin, W. S. (2000). Interleukin-1 and the immunogenetics of Alzheimer disease. J Neuropathol Exp Neurol, 59, 471-476
105. Mucke, L., Masliah, E., Yu, G. Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K. and McConlogue, L. (2000). High-level neuronal expression of Abeta 1-42 in wild-Type human amyloid protein precursor transgenic mice: Synaptotoxicity without plaque formation. J Neurosci, 20, 4050-4058
106. Mullan, M., Crawford, F., Axelman, K., Houlden, H., Lilius, L., Winblad, B. and Lannfelt, L. (1992). A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-Terminus of beta-Amyloid. Nat Genet, 1, 345-347
107. Murrell, J., Farlow, M., Ghetti, B. and Benson, M. D. (1991). A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science, 254, 97-99
108. Noda, M., Nakanishi, H. and Akaike, N. (1999). Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide. Neuroscience, 92, 1465-1474
109. O'Banion, M. K., Chang, J. W., Kaplan, M. D., Yermakova, A. and Coleman, P. D. (1997). Glial and neuronal expression of cyclooxygenase-2: Relevance to Alzheimer's disease. Adv Exp Med Biol, 433, 177-180
110. Okamoto, T., Takeda, S., Murayama, Y., Ogata, E. and Nishimoto, I. (1995). Ligand-dependent G protein coupling function of amyloid transmembrane precursor. J Biol Chem, 270, 4205-4208
111. Pike, C J., Burdick, D., Walencewicz, A. J., Glabe, C. G. and Cotman, C. W. (1993). Neurodegeneration induced by beta-Amyloid peptides in vitro: The role of peptide assembly state. J Neurosci, 13, 1676-1687
112. Podlisny, M. B., Ostaszewski, B. L., Squazzo, S. L., Koo, E. H., Rydell, R. E., Teplow, D. B. and Selkoe, D. J. (1995). Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture. J Biol Chem, 270, 9564-9570.
113. Pooler, A. M., Arjona, A. A., Lee, R. K. and Wurtman, R. J. (2004). Prostaglandin E2 regulates amyloid precursor protein expression via the EP2 receptor in cultured rat microglia. Neurosci Lett, 362, 127-130
114. Roher, A E., Chaney, M. O., Kuo, Y. M., Webster, S. D., Stine, W. B., Haverkamp, L. J., Woods, A. S., Cotter, R. J., Tuohy, J. M., Krafft, G. A., Bonnell, B. S. and Emmerling, M. R. (1996). Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease. J Biol Chem, 271, 20631-20635
115. Rossjohn, J., Cappai, R., Feil, S. C., Henry, A., McKinstry, W. J., Galatis, D., Hesse, L., Multhaup, G., Beyreuther, K., Masters, C. L. and Parker, M. W. (1999). Crystal structure of the N-Terminal, growth factor-like domain of Alzheimer amyloid precursor protein. Nat Struct Biol, 6, 327-331
116. Sabo, S. L., Ikin, A. F., Buxbaum, J. D. and Greengard, P. (2001). The Alzheimer amyloid precursor protein (APP) and FE65, an APP-binding protein, regulate cell movement. J Cell Biol, 153, 1403-1414
117. Sasaki, A., H. Yamaguchi, A. Ogawa, S. Sugihara and Y. Nakazato (1997). Microglial activation in early stages of amyloid beta protein Deposition. Acta Neuropathol (Berl), 94, 316-322
118. Scheuermann, S., Hambsch, B., Hesse, L., Stumm, J., Schmidt, C., Beher, D., Bayer, T. A., Beyreuther, K. and Multhaup, G. (2001). Homodimerization of amyloid precursor protein and its implication in the amyloidogenic pathway of Alzheimer's disease. J Biol Chem, 276, 33923-33929
119. Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., Larson, E., Levy-Lahad, E., Viitanen, M., Peskind, E., Poorkaj, P., Schellenberg, G., Tanzi, R., Wasco, W., Lannfelt, L., Selkoe, D. and Younkin, S. (1996). Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med, 2, 864-870
120. Schmechel, D. E., Goldgaber, D., Burkhart, D. S., Gilbert, J. R., Gajdusek, D. C. and Roses, A. D. (1988). Cellular localization of messenger RNA encoding amyloid-beta-protein in normal tissue and in Alzheimer disease. Alzheimer Dis Assoc Disord, 2, 96-111
121. Schulz, J. G., Megow, D., Reszka, R., Villringer, A., Einhaupl, K. M. and Dirnagl, U. (1998). Evidence that glypican is a receptor mediating beta-Amyloid neurotoxicity in PC12 cells. Eur J Neurosci, 10, 2085-2093
122. Scott, S. A., Johnson, S. A., Zarow, C. and Perlmutter, L. S. (1993). Inability to detect betaamyloid protein precursor mRNA in Alzheimer plaque-Associated microglia. Exp Neurol, 121, 113-118
123. Selkoe, D. J. (2001). Alzheimer's disease: Henes, proteins, and therapy. Physiol Rev, 81, 741-766
124. Selkoe, D. J. (2002). Alzheimer's disease is a synaptic failure. Science, 298, 789-791
125. Selkoe, D. J. (2005). Defining molecular targets to prevent Alzheimer disease. Arch Neurol, 62, 192-195
126. Shaked, G. M., Kummer, M. P., Lu, D. C., Galvan, V., Bredesen, D. E. and Koo, E. H. (2006). Abeta induces cell death by direct interaction with its cognate extracellular domain on APP (APP 597-624). FASEB J, 20, 1254-1256
127. Sheng, J. G., Mrak, R. E. and Griffin, W. S. (1995). Microglial interleukin-1 alpha expression in brain regions in Alzheimer's disease: Correlation with neuritic plaque distribution. Neuropathol Appl Neurobiol, 21, 290-301
128. Sheng, J. G., Mrak, R. E. and Griffin, W. S. (1997). Neuritic plaque evolution in Alzheimer's disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms. Acta Neuropathol (Berl), 94, 1-5
129. Sheng, J. G., Griffin, W. S., Royston, M. C. and Mrak, R. E. (1998). Distribution of interleukin-1-immunoreactive microglia in cerebral cortical layers: Implications for neuritic plaque formation in Alzheimer's disease. Neuropathol Appl Neurobiol, 24, 278-283
130. Sinha, S. and Lieberburg, I. (1999). Cellular mechanisms of beta-Amyloid production and secretion. Proc Natl Acad Sci U S A, 96, 11049-11053
131. Sinha, S., Anderson, J. P., Barbour, R., Basi, G. S., Caccavello, R., Davis, D., Doan, M., Dovey, H. F., Frigon, N., Hong, J., Jacobson-Croak, K., Jewett, N., Keim, P., Knops, J., Lieberburg, I., Power, M., Tan, H., Tatsuno, G., Tung, J., Schenk, D., Seubert, P., Suomensaari, S. M., Wang, S., Walker, D., Zhao, J., McConlogue, L. and John, V. (1999). Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature, 402, 537-540
132. Sondag, C M. and Combs, C. K. (2004). Amyloid precursor protein mediates proinflammatory activation of monocytic lineage cells. J Biol Chem, 279, 14456-14463
133. Sondag, C M. and Combs, C. K. (2006). Amyloid precursor protein cross-linking stimulates beta amyloid production and pro-inflammatory cytokine release in monocytic lineage cells. J Neurochem, 97, 449-461
134. Strauss, S., Bauer, J., Ganter, U., Jonas, U., Berger, M. and Volk, B. (1992). Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Lab Invest, 66, 223-230
135. Suzuki, N., Cheung, T. T., Cai, X. D., Odaka, A., Otvos, L., Jr., Eckman, C., Golde, T. E. and Younkin, S. G. (1994). An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science, 264, 1336-1340
136. Takata, K., Kitamura, Y., Umeki, M., Tsuchiya, D., Kakimura, J., Taniguchi, T., Gebicke-Haerter, P. J. and Shimohama, S. (2003). Possible involvement of small oligomers of amyloid-beta peptides in 15-deoxy-delta 12,14 prostaglandin J2-sensitive microglial activation. J Pharmacol Sci, 91, 330-333
137. Tan, J., Town, T. and Mullan, M. (2000). CD45 inhibits CD40L-induced microglial activation via negative regulation of the Src/p44/42 MAPK pathway. J Biol Chem, 275, 37224-37231
138. Tarr, P. E., Roncarati, R., Pelicci, G., Pelicci, P. G. and D'Adamio, L. (2002). Tyrosine phosphorylation of the beta-Amyloid precursor protein cytoplasmic tail promotes interaction with Shc. J Biol Chem, 277, 16798-16804
139. Twig, G., Graf, S. A., Messerli, M. A., Smith, P. J., Yoo, S. H. and Shirihai, O. S. (2005). Synergistic amplification of beta-Amyloid- And interferon-gamma-induced microglial neurotoxic response by the senile plaque component chromogranin A. Am J Physiol Cell Physiol, 288, C169-C175
140. Van Nostrand, W. E., Melchor, J. P., Keane, D. M., Saporito-Irwin, S. M., Romanov, G., Davis, J. and Xu, F. (2002). Localization of a fibrillar amyloid beta-protein binding domain on its precursor. J Biol Chem, 277, 36392-36398
141. Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., Luo, Y., Fisher, S., Fuller, J., Edenson, S., Lile, J., Jarosinski, M. A., Biere, A. L., Curran, E., Burgess, T., Louis, J. C., Collins, F., Treanor, J., Rogers, G. and Citron, M. (1999). Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science, 286, 735-741
142. Wagner, M. R., Keane, D. M., Melchor, J. P., Auspaker, K. R. and Van Nostrand, W. E. (2000). Fibrillar amyloid beta-protein binds protease nexin-2/amyloid beta-protein precursor: Stimulation of its inhibition of coagulation factor XIa. Biochemistry, 39, 7420-7427
143. Walker, D. G., Lue, L. F. and Beach, T. G. (2001). Gene expression profiling of amyloid beta peptide-stimulated human post-mortem brain microglia. Neurobiol Aging, 22, 957-966
144. Walker, D G., Link, J., Lue, L. F., Dalsing-Hernandez, J. E. and Boyes, B. E. (2006). Gene expression changes by amyloid beta peptide-stimulated human postmortem brain microglia identify activation of multiple inflammatory processes. J Leukoc Biol, 79, 596-610
145. Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J. and Selkoe, D. J. (2002). Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-Term potentiation in vivo. Nature, 416, 535-539
146. Walsh, D. M., Townsend, M., Podlisny, M. B., Shankar, G. M., Fadeeva, J. V., El Agnaf, O., Hartley, D. M. and Selkoe, D. J. (2005). Certain inhibitors of synthetic amyloid beta-peptide (Abeta) fibrillogenesis block oligomerization of natural Abeta and thereby rescue long-Term potentiation. J Neurosci, 25, 2455-2462
147. Wang, Y. and Ha, Y. (2004). The X-ray structure of an antiparallel dimer of the human amyloid precursor protein E2 domain. Mol Cell, 15, 343-353
148. Wang, H. Y., Lee, D. H., Davis, C. B. and Shank, R. P. (2000). Amyloid peptide Abeta(1-42) binds selectively and with picomolar affinity to alpha7 nicotinic acetylcholine receptors. J Neurochem, 75, 1155-1161
149. Wang, H. W., Pasternak, J. F., Kuo, H., Ristic, H., Lambert, M. P., Chromy, B., Viola, K. L., Klein, W. L., Stine, W. B., Krafft, G. A. and Trommer, B. L. (2002). Soluble oligomers of beta amyloid (1-42) inhibit long-Term potentiation but not long-Term depression in rat dentate gyrus. Brain Res, 924, 133-140
150. Weidemann, A., Konig, G., Bunke, D., Fischer, P., Salbaum, J. M., Masters, C. L. and Beyreuther, K. (1989). Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell, 57, 115-126
151. Westerman, M A., Cooper-Blacketer, D., Mariash, A., Kotilinek, L., Kawarabayashi, T., Younkin, L. H., Carlson, G. A., Younkin, S. G. and Ashe, K. H. (2002). The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. J Neurosci, 22, 1858-1867
152. White, J. A., Manelli, A. M., Holmberg, K. H., Van Eldik, L. J. and Ladu, M. J. (2005). Differential effects of oligomeric and fibrillar amyloid-beta 1-42 on astrocyte-mediated inflammation. Neurobiol Dis, 18, 459-465
153. Wilkinson, B., Koenigsknecht-Talboo, J., Grommes, C., Lee, C. Y. and Landreth, G. (2006). Fibrillar beta-Amyloid-stimulated intracellular signaling cascades require Vav for induction of respiratory burst and phagocytosis in monocytes and microglia. J Biol Chem, 281, 20842-20850
154. Williamson, T G., Nurcombe, V., Beyreuther, K., Masters, C. L. and Small, D. H. (1995). Affinity purification of proteoglycans that bind to the amyloid protein precursor of Alzheimer's disease. J Neurochem, 65, 2201-2208
155. Wu, S Z., Bodles, A. M., Porter, M. M., Griffin, W. S., Basile, A. S. and Barger, S. W. (2004). Induction of serine racemase expression and D-serine release from microglia by amyloid betapeptide. J Neuroinflammation, 1, 2
156. Xia, W., Zhang, J., Kholodenko, D., Citron, M., Podlisny, M. B., Teplow, D. B., Haass, C., Seubert, P., Koo, E. H. and Selkoe, D. J. (1997). Enhanced production and oligomerization of the 42-residue amyloid beta-protein by Chinese hamster ovary cells stably expressing mutant presenilins. J Biol Chem, 272, 7977-7982
157. Xiang, Z., Haroutunian, V., Ho, L., Purohit, D. and Pasinetti, G. M. (2006). Microglia activation in the brain as inflammatory biomarker of Alzheimer's disease neuropathology and clinical dementia. Dis Markers, 22, 95-102
158. Xie, L., Helmerhorst, E., Taddei, K., Plewright, B., Van Bronswijk, W. and Martins, R. (2002a). Alzheimer's beta-Amyloid peptides compete for insulin binding to the insulin receptor. J Neurosci, 22, RC221
159. Xie, Z., M. Wei, T. E. Morgan, P. Fabrizio, D. Han, C. E. Finch and V. D. Longo (2002b). Peroxynitrite mediates neurotoxicity of amyloid beta-peptide1-42- And lipopolysaccharideactivated microglia. J Neurosci, 22, 3484-3492
160. Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., Migheli, A., Nawroth, P., Stern, D. and Schmidt, A. M. (1996). RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature, 382, 685-691
161. Yates, S L., Burgess, L. H., Kocsis-Angle, J., Antal, J. M., Dority, M. D., Embury, P. B., Piotrkowski, A. M. and Brunden, K. R. (2000). Amyloid beta and amylin fibrils induce increases in proinflammatory cytokine and chemokine production by THP-1 cells and murine microglia. J Neurochem, 74, 1017-1025
162. Yazawa, H., Yu, Z. X., Takeda, Le, Y., Gong, W., Ferrans, V. J., Oppenheim, J. J., Li, C. C. and Wang, J. M. (2001). Beta amyloid peptide (Abeta42) is internalized via the G-protein-coupled receptor FPRL1 and forms fibrillar aggregates in macrophages. FASEB J, 15, 2454-2462